{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:36:01Z","timestamp":1793367361643,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Mechanistic Investigation of Lycium barbarum Polysaccharide-Induced Effects on Human Breast Cancer Cells via the Hippo Signaling Pathway","award":["2023AAC03719"],"award-info":[{"award-number":["2023AAC03719"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-34454-w","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T12:20:45Z","timestamp":1771244445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["LBPs NPs suppress breast cancer progression by inhibiting YAP1 expression to induce ferroptosis and alter energy metabolism"],"prefix":"10.1038","volume":"16","author":[{"given":"Fangfang","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juying","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"34454_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s40659-017-0140-9","volume":"50","author":"M Akram","year":"2017","unstructured":"Akram, M., Iqbal, M., Daniyal, M. & Khan, A. U. Awareness and current knowledge of breast cancer. Biol. Res. 50, 33 (2017).","journal-title":"Biol. Res."},{"key":"34454_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong, X. et al. Breast cancer: pathogenesis and treatments. Signal. Transduct. Target. Therapy. 10, 49 (2025).","journal-title":"Signal. Transduct. Target. Therapy"},{"key":"34454_CR3","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.2147\/DDDT.S472178","volume":"18","author":"Y Luo","year":"2024","unstructured":"Luo, Y. et al. Ferroptosis in cancer therapy: Mechanisms, small molecule Inducers, and novel approaches. Drug. Des. Devel. Ther. 18, 2485\u20132529 (2024).","journal-title":"Drug. Des. Devel. Ther."},{"key":"34454_CR4","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer cell. 42, 513\u2013534 (2024).","journal-title":"Cancer cell."},{"key":"34454_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size Control, tissue Homeostasis, and cancer. Cell 163, 811\u2013828 (2015).","journal-title":"Cell"},{"key":"34454_CR6","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1158\/0008-5472.CAN-23-3074","volume":"84","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. FOXP4 is a direct YAP1 target that promotes gastric cancer stemness and drives metastasis. Cancer Res. 84, 3574\u20133588 (2024).","journal-title":"Cancer Res."},{"key":"34454_CR7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato, F., Cordenonsi, M. & Piccolo, S. YAP\/TAZ at the roots of cancer. Cancer cell. 29, 783\u2013803 (2016).","journal-title":"Cancer cell."},{"key":"34454_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41419-024-06464-5","volume":"15","author":"Y Gu","year":"2024","unstructured":"Gu, Y. et al. CYLD regulates cell ferroptosis through Hippo\/YAP signaling in prostate cancer progression. Cell Death Dis. 15, 79 (2024).","journal-title":"Cell Death Dis."},{"key":"34454_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3892\/ol.2024.14576","volume":"28","author":"H Li","year":"2024","unstructured":"Li, H., Wu, Y., Ma, Y. & Liu, X. Interference with ENO2 promotes ferroptosis and inhibits Glycolysis in clear cell renal cell carcinoma by regulating Hippo\u2013YAP1 signaling. Oncol. Lett. 28, 443 (2024).","journal-title":"Oncol. Lett."},{"key":"34454_CR10","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1631\/jzus.B2100748","volume":"23","author":"X Du","year":"2022","unstructured":"Du, X. et al. A novel anticancer property of lycium barbarum polysaccharide in triggering ferroptosis of breast cancer cells. J. Zhejiang Univ. Sci. B. 23, 286\u2013299 (2022).","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"34454_CR11","first-page":"7369","volume":"10","author":"Q Chen","year":"2017","unstructured":"Chen, Q., Shi, R., Jiang, D., Liu, W. & Jia, Z. Lycium barbarum polysaccharide inhibits gastric cancer cell proliferation, migration and invasion by down-regulation of MMPs and suppressing epithelial-mesenchymal transition. Int. J. Clin. Exp. Pathol. 10, 7369\u20137374 (2017).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"34454_CR12","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.18632\/oncotarget.13963","volume":"8","author":"XJ Zhang","year":"2017","unstructured":"Zhang, X. J., Yu, H. Y., Cai, Y. J. & Ke, M. Lycium barbarum polysaccharides inhibit proliferation and migration of bladder cancer cell lines BIU87 by suppressing Pi3K\/AKT pathway. Oncotarget 8, 5936\u20135942 (2017).","journal-title":"Oncotarget"},{"key":"34454_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ijbiomac.2015.12.089","volume":"85","author":"R Bo","year":"2016","unstructured":"Bo, R. et al. The immunological activity of lycium barbarum polysaccharides liposome in vitro and adjuvanticity against PCV2 in vivo. Int. J. Biol. Macromol. 85, 294\u2013301 (2016).","journal-title":"Int. J. Biol. Macromol."},{"key":"34454_CR14","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1080\/10717544.2022.2094498","volume":"29","author":"B Li","year":"2022","unstructured":"Li, B. et al. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: A review. Drug Deliv. 29, 2130\u20132161 (2022).","journal-title":"Drug Deliv."},{"key":"34454_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s13046-021-02012-7","volume":"40","author":"J Yang","year":"2021","unstructured":"Yang, J. et al. Metformin induces ferroptosis by inhibiting ufmylation of SLC7A11 in breast cancer. J. Exp. Clin. Cancer Res.: CR. 40, 206 (2021).","journal-title":"J. Experimental Clin. Cancer Research: CR"},{"key":"34454_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell, B. R. et al. Ferroptosis: A regulated cell death nexus linking Metabolism, redox Biology, and disease. Cell 171, 273\u2013285 (2017).","journal-title":"Cell"},{"key":"34454_CR17","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1042\/CS20201474","volume":"136","author":"R Cunningham","year":"2022","unstructured":"Cunningham, R. & Hansen, C. G. The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin. Sci. (London England: 1979). 136, 197\u2013222 (2022).","journal-title":"Clin. Sci. (London England: 1979)"},{"key":"34454_CR18","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.tibs.2017.09.003","volume":"42","author":"KC Lin","year":"2017","unstructured":"Lin, K. C., Park, H. W. & Guan, K. L. Regulation of the Hippo pathway transcription factor TEAD. Trends Biochem. Sci. 42, 862\u2013872 (2017).","journal-title":"Trends Biochem. Sci."},{"key":"34454_CR19","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1128\/MCB.01874-07","volume":"28","author":"QY Lei","year":"2008","unstructured":"Lei, Q. Y. et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway. Mol. Cell. Biol. 28, 2426\u20132436 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"34454_CR20","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/jcb.27544","volume":"120","author":"S Koohestanimobarhan","year":"2019","unstructured":"Koohestanimobarhan, S., Salami, S., Imeni, V., Mohammadi, Z. & Bayat, O. Lipophilic Statins antagonistically alter the major epithelial-to-mesenchymal transition signaling pathways in breast cancer stem-like cells via Inhibition of the mevalonate pathway. J. Cell. Biochem. 120, 2515\u20132531 (2019).","journal-title":"J. Cell. Biochem."},{"key":"34454_CR21","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.2217\/fon-2020-1080","volume":"17","author":"J Qadir","year":"2021","unstructured":"Qadir, J. et al. Increased YAP1 expression is significantly associated with breast cancer progression, metastasis and poor survival. Future Oncol. (London England). 17, 2725\u20132734 (2021).","journal-title":"Future Oncol. (London England)"},{"key":"34454_CR22","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.gendis.2020.05.004","volume":"8","author":"T Sun","year":"2021","unstructured":"Sun, T. & Chi, J. T. Regulation of ferroptosis in cancer cells by YAP\/TAZ and Hippo pathways: The therapeutic implications. Genes Dis. 8, 241\u2013249 (2021).","journal-title":"Genes Dis."},{"key":"34454_CR23","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1158\/1541-7786.MCR-20-0534","volume":"19","author":"WH Yang","year":"2021","unstructured":"Yang, W. H. et al. The Hippo pathway effector YAP promotes ferroptosis via the E3 ligase SKP2. Mol. Cancer Research: MCR. 19, 1005\u20131014 (2021).","journal-title":"Mol. Cancer Research: MCR"},{"key":"34454_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41586-019-1426-6","volume":"572","author":"J Wu","year":"2019","unstructured":"Wu, J. et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature 572, 402\u2013406 (2019).","journal-title":"Nature"},{"key":"34454_CR25","doi-asserted-by":"publisher","first-page":"1367747","DOI":"10.3389\/fphar.2024.1367747","volume":"15","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Lycium barbarum polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K\/AKT-dependent phosphomannose isomerase. Front. Pharmacol. 15, 1367747 (2024).","journal-title":"Front. Pharmacol."},{"key":"34454_CR26","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12032-009-9286-9","volume":"27","author":"Y Miao","year":"2010","unstructured":"Miao, Y. et al. Growth Inhibition and cell-cycle arrest of human gastric cancer cells by lycium barbarum polysaccharide. Med. Oncol. (Northwood Lond. Engl.). 27, 785\u2013790 (2010).","journal-title":"Med. Oncol. (Northwood Lond. Engl.)"},{"key":"34454_CR27","doi-asserted-by":"publisher","first-page":"145030","DOI":"10.1016\/j.ijbiomac.2025.145030","volume":"318","author":"YL Ma","year":"2025","unstructured":"Ma, Y. L. et al. Zein\/Lycium barbarum polysaccharide\/chlorogenic acid composite nanoparticles: construction, characterization, physicochemical and biological properties. Int. J. Biol. Macromol. 318, 145030 (2025).","journal-title":"Int. J. Biol. Macromol."},{"key":"34454_CR28","doi-asserted-by":"publisher","first-page":"36194","DOI":"10.1038\/s41598-025-20012-x","volume":"15","author":"\u015e \u015eahin","year":"2025","unstructured":"\u015eahin, \u015e., Kaya-Tilki, E., Baysal, M. & \u00d6zt\u00fcrk, A. A. Preparation and evaluation of Temozolomide loaded PLGA nanoparticles for the treatment of glioblastoma multiforme. Sci. Rep. 15, 36194 (2025).","journal-title":"Sci. Rep."},{"key":"34454_CR29","doi-asserted-by":"publisher","first-page":"36615","DOI":"10.31083\/FBL36615","volume":"30","author":"S Wu","year":"2025","unstructured":"Wu, S. et al. Aldo-keto reductase 1B10 (AKR1B10) suppresses sensitivity of ferroptosis in TNBC by activating the AKT\/GSK3\u03b2\/Nrf2\/GPX4 axis. Front. Biosci. (Landmark edition). 30, 36615 (2025).","journal-title":"Front. Bioscience (Landmark edition)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34454-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34454-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34454-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:17:46Z","timestamp":1773825466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-34454-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["34454"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-34454-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9257"}}